🔴 We are now live with an insightful presentation by Dr. Stefano Cinti, PhD, Associate Professor of Analytical Chemistry at the University of Naples Federico II, Italy, exploring the next generation of point-of-care technologies for liquid biopsy.
Presentation: Point-of-Care for Liquid Biopsy: From Diagnosis to Therapy Evaluation
Point-of-care technologies are redefining how liquid biopsy can be integrated into everyday clinical practice, making cancer diagnostics faster, more accessible, and more patient-centered. In this session, Dr. Cinti is showcasing innovative analytical platforms designed to bring advanced molecular testing closer to the bedside.
Drawing on his expertise in biosensors, electrochemical diagnostics, microfluidics, and nanotechnology, Dr. Cinti highlights how portable liquid biopsy devices can rapidly detect circulating tumor DNA (ctDNA), RNA, and other clinically relevant biomarkers with high sensitivity and accuracy.
The presentation explores how these emerging technologies can support early cancer diagnosis, real-time treatment monitoring, therapy evaluation, and personalized clinical decision-making, helping bridge the gap between laboratory innovation and routine healthcare.
This engaging session demonstrates how point-of-care liquid biopsy is poised to transform precision oncology by delivering rapid, minimally invasive diagnostics that improve patient care and clinical outcomes.
We extend our sincere thanks to Dr. Stefano Cinti for sharing his expertise and to our global audience for joining us in today’s scientific discussions.
This conference is organized by Impact Research Communications (IRC)
More info: https://liquidbio.ircconferences.net/ | Advances in Liquid Biopsy
